These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25002625)

  • 1. A MYOD1 mutation cooperates with PI3K pathway activation in ERMS.
    Cancer Discov; 2014 Jul; 4(7):OF19. PubMed ID: 25002625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
    Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
    Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway].
    Orbach D
    Bull Cancer; 2014 Sep; 101(9):776-7. PubMed ID: 25295632
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
    Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
    Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
    J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
    Agard H; Clark C; Massanyi E; Steele M; McMahon D
    Urology; 2020 Mar; 137():173-177. PubMed ID: 31945380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
    Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
    Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
    Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
    Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting oxidative stress in embryonal rhabdomyosarcoma.
    Chen X; Stewart E; Shelat AA; Qu C; Bahrami A; Hatley M; Wu G; Bradley C; McEvoy J; Pappo A; Spunt S; Valentine MB; Valentine V; Krafcik F; Lang WH; Wierdl M; Tsurkan L; Tolleman V; Federico SM; Morton C; Lu C; Ding L; Easton J; Rusch M; Nagahawatte P; Wang J; Parker M; Wei L; Hedlund E; Finkelstein D; Edmonson M; Shurtleff S; Boggs K; Mulder H; Yergeau D; Skapek S; Hawkins DS; Ramirez N; Potter PM; Sandoval JA; Davidoff AM; Mardis ER; Wilson RK; Zhang J; Downing JR; Dyer MA;
    Cancer Cell; 2013 Dec; 24(6):710-24. PubMed ID: 24332040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
    Yu L; Wang J
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female.
    Pena-Burgos EM; De Sabando DP; Utrilla C; Pozo-Kreilinger JJ; Sastre A; Rubio P; Escudero A; Mendiola-Sabio M; Pérez-Martínez A
    Head Neck Pathol; 2023 Sep; 17(3):855-863. PubMed ID: 36913073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (2;8)(q35;q13): a recurrent abnormality in congenital embryonal rhabdomyosarcoma.
    Meloni-Ehrig A; Smith B; Zgoda J; Greenberg J; Perdahl-Wallace E; Zaman S; Mowrey P
    Cancer Genet Cytogenet; 2009 May; 191(1):43-5. PubMed ID: 19389508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.
    Sebire NJ; Malone M
    J Clin Pathol; 2003 Jun; 56(6):412-6. PubMed ID: 12783965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.
    Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR
    Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.